Shen, Y. ., Chen, X. ., Zhang, H. ., & Hu, . H. (2024). Long-term cost-effectiveness analysis of onceweekly Semaglutide versus Dulaglutide for the treatment of type 2 diabetes after the renewal of the national drug reimbursement list in China. Health Decision, 2(S1). https://doi.org/10.54844/hd.2024.0003